title: Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
authors.affiliation: Medizinische Klinik und Poliklinik, Klinik für Nephrologie und Rheumatologie der Heinrich-Heine-Universität, Düsseldorf, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Blume
authors.forename: M
authors.initials: M
authors.lastname: Hollenbeck
authors.forename: K
authors.initials: K
authors.lastname: Ivens
authors.forename: P
authors.initials: P
authors.lastname: Heering
authors.forename: G R
authors.initials: GR
authors.lastname: Hetzel
authors.forename: B
authors.initials: B
authors.lastname: Grabensee
mesh_terms: D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D012189:Retrospective Studies; D013256:Steroids / Q000009:adverse effects / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D003404:Creatinine; D016559:Tacrolimus